Wave Life Sciences Ltd. ($WVE)
Filing Information
| Accession Number | 0001193125-26-047319 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 12, 2026 |
| Document Date | Feb 5, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
273,133
Total Value
$25,326.35
P&L
+inf% (+$3,189,900.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SVP, Corporate Development, Head of Emerging Areas | Ordinary Shares | โ | Feb 5, 2026 | Grant/Award | 38,750 | $0.00 | $0.00 | 63,750 | Direct | โ | View Details | |
SVP, Corporate Development, Head of Emerging Areas | Ordinary Shares | โ | Feb 9, 2026 | Sale | 1,883 | $13.45 | $25,326.35 | 61,867 | Direct | โ | View Details | |
SVP, Corporate Development, Head of Emerging Areas | Share Option (right to buy) | Derivative | Feb 5, 2026 | Grant/Award | 232,500 | $0.00 | $0.00 | 232,500 | Direct | โ | View Details |